- Product Details
Keywords
- Pharmaceutical grade
- Manufacturer (audit and TDP support)
- Nucleotide and Nucleoside
Quick Details
- ProName: Inosine
- CasNo: 58-63-9
- Molecular Formula: C10H12N4O5
- Appearance: White crystalline powder
- Application: As an important intermediate in food a...
- DeliveryTime: within 1 weeks
- PackAge: standard package
- Port: TBC
- ProductionCapacity: commercial production Metric Ton/Day
- Purity: 99.5%
- Storage: Keep in dark place,Sealed in dry,Room ...
- Transportation: Non-hazardous
- LimitNum: 1 Kilogram
- Moisture Content: ≤0.5%
- Impurity: <0.5%
- any individual impurity: ≤ 0.1%
Superiority
Central production base:
Located in Henan Province, central China.
It is integrating biological fermentation, protein engineering and chemical synthesis, specializing in the production of nucleosides, nucleotides and derivatives.
Currently produce: Inosine, Guanosine, IMP (Disodium 5'-inosinate), GMP (5'-guanylate disodium), I+G ( IMP+GMP) and Sodium pyrophosphate (SAPP).
SAPP annual output: over 10,000 mt
SAPP is the side product of I+G.
Commercial production with technical documents package support, and audit and inspection support.
With high purity and optimized and stable process.
Self Innovation
Details
MW: 268.23
Self Innovation
SENOVA PHARMA is committed to the development and production of API’s, advanced intermediates and biochemical products.
We insist on product development and production technology platform combining chemical synthesis (drug synthesis) technology, enzyme synthesis (biocatalytic and biotransformation) technology and microbial fermentation (biosynthesis) technology.
Our own production base in China produce products according to cGMP application, providing customers with stable and reliable whole-chain solutions, esp in anti-virus field.